Seed Co Ltd

Seed Co Ltd maintains a debt-to-equity ratio of 1.45, indicating a moderate reliance on debt financing, while its liquidity position is assessed as medium. The company's price-to-book ratio of 0.91 suggests that its market value is slightly below its book value, and its price-to-tangible-book ratio is identical, implying no significant intangible asset premium. The company's current ratio of 1.14 indicates a modest ability to cover short-term liabilities with current assets. Profitability metrics show a return on equity (ROE) of 6.05% and a return on assets (ROA) of 2.11%, both below the industry median for Medical Equipment, Supplies & Distribution. The company's operating margin is 4.78% (calculated from operating income of ¥15.9 billion on revenue of ¥33.2 billion), which is also below the industry median. This suggests that Seed Co Ltd is underperforming in terms of capital efficiency and operational profitability relative to its peers. The company's revenue is concentrated in its Contact Lens and Care Products segment, which accounts for the majority of its business. Geographically, the company is primarily focused on the Japanese market, with no significant international revenue disclosed in the financial snapshot. This concentration may expose the company to regional economic and regulatory risks. Looking ahead, the company's revenue is expected to grow modestly, with analysts forecasting ¥34 billion in revenue for the current fiscal year, compared to actual revenue of ¥33.23 billion. The company's free cash flow is negative at ¥690 million, driven by capital expenditures of ¥4.72 billion, which may signal ongoing investment in production or R&D. However, the company's operating cash flow of ¥2.98 billion provides some buffer against near-term liquidity pressures. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The risk assessment highlights that net cash is negative after subtracting total debt, which could constrain the company's ability to fund operations or growth initiatives without external financing. No significant dilution sources are identified in the current period, and the company's diluted shares are equal to its basic shares, indicating no material dilution pressure. Recent events include the publication of the latest financial snapshot, which includes revenue, operating income, and net income figures. Analysts have provided estimates for the upcoming fiscal year, with a mean EPS estimate of ¥34.00 and a mean revenue estimate of ¥34 billion. The company's actual EPS of ¥36.10 and revenue of ¥33.23 billion suggest that it has slightly outperformed expectations in the most recent period.